Yes, lisdexamfetamine is a Schedule II controlled substance in the United States, the same category as oxycodone, fentanyl, and other amphetamines. The DEA placed it in Schedule II in 2007 based on three findings: it has a high potential for abuse, it has accepted medical uses, and misuse can lead to severe psychological or physical dependence. This classification shapes how the drug is prescribed, dispensed, and stored.
What Schedule II Means in Practice
The Controlled Substances Act ranks drugs on a five-tier system. Schedule I (like heroin) has no accepted medical use. Schedule II includes drugs that are medically useful but carry a high risk of abuse and dependence. Lisdexamfetamine sits alongside other stimulants and potent painkillers in this category.
For you as a patient, Schedule II status means several concrete things. Pharmacies cannot give you refills on a single prescription. Each time you need more medication, your doctor must write a new prescription. Federal rules do allow a workaround: your doctor can write up to three separate 30-day prescriptions at once, with each one dated so the pharmacy knows the earliest it can be filled. That gives you up to a 90-day supply without needing three separate office visits, but many states and insurance plans still require monthly check-ins. All Schedule II prescriptions must be sent electronically in most states.
Why It’s Classified This Way
Lisdexamfetamine (sold as Vyvanse and now available as a generic) is a prodrug, meaning it’s inactive when you swallow it. Your body has to convert it before it works. The capsule or tablet contains a molecule where the active ingredient, dextroamphetamine, is bonded to an amino acid called lysine. After you take it, enzymes inside your red blood cells break that bond and release the dextroamphetamine gradually.
This conversion step is the key difference between lisdexamfetamine and older stimulants. Immediate-release dextroamphetamine reaches its peak concentration in the blood within about 2 to 3 hours. Lisdexamfetamine takes roughly 4 hours, and the peak itself is lower. That slower, flatter rise produces less of the rush that makes stimulants appealing to misuse. In clinical studies comparing the two in adults with a history of stimulant abuse, people rated the “liking” effect of a standard therapeutic dose of lisdexamfetamine about the same as a placebo, while the equivalent dose of immediate-release dextroamphetamine scored significantly higher. Only at very high doses (150 mg, well above the typical therapeutic range) did lisdexamfetamine’s liking scores approach those of dextroamphetamine.
Despite this reduced abuse profile at normal doses, the DEA determined that lisdexamfetamine still warrants Schedule II placement because it ultimately delivers the same active compound. Higher doses can still produce euphoria, and the drug can still lead to dependence.
FDA-Approved Uses
Lisdexamfetamine is approved for two conditions: ADHD in patients six years and older, and moderate to severe binge eating disorder in adults. The FDA approved several generic versions, making the medication more accessible than when only the brand name Vyvanse was available.
Ongoing Shortages and Production Limits
Because lisdexamfetamine is Schedule II, the DEA sets a cap each year on how much can be manufactured in the United States. In September 2025, the DEA raised the annual production quota from roughly 32.7 million grams to nearly 39.9 million grams after multiple manufacturers reported domestic shortages of lisdexamfetamine capsules and chewable tablets. Global consumption of the drug is projected to rise about 15 percent in 2025. If you’ve had trouble finding your medication at the pharmacy, these production limits are part of the reason, though the DEA adjusts them when shortages are confirmed.
Storing Your Medication Safely
Federal guidelines recommend that controlled substances be kept in a secure location at home, away from other people and especially out of reach of children. Some patients use a lockbox or a locked cabinet. The goal is to prevent accidental ingestion and theft, both of which are more common with Schedule II drugs than with non-controlled medications. State laws vary on specific requirements, but the principle is the same everywhere: treat these pills as something worth securing.
Traveling With Lisdexamfetamine
Traveling domestically with a Schedule II medication is straightforward as long as you keep it in its original pharmacy container with the prescription label visible. International travel is more complicated. U.S. Customs and Border Protection advises that you declare all controlled substances when crossing borders, carry them in original containers, bring only a personal-use quantity, and have a written statement from your doctor confirming the prescription is medically necessary. Many countries have their own import rules for controlled stimulants, and some require an advance permit. Check with the embassy or consulate of your destination country before you fly.
Legal Status Outside the US
Lisdexamfetamine is controlled in most countries where it’s available, though the specific classification varies. In the United Kingdom, it’s a Class B drug under the Misuse of Drugs Act, grouped alongside other amphetamines. In Australia, it’s classified as a Schedule 8 controlled drug under the Poisons Standard, the most restrictive category for medications that are still prescribable. These classifications carry similar practical consequences to the US system: limited prescription quantities, no automatic refills, and restrictions on who can prescribe the drug.